The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus.

Source:http://linkedlifedata.com/resource/pubmed/id/21813775

J. Immunol. 2011 Sep 1 187 5 2602-16

Download in:

View as

General Info

PMID
21813775